Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 6991-6998

  Campanella, Gabriele S V ^a   Grimm, Jan ^a   Manice, Lindsay A ^a   Colvin, Richard A ^a   Medoff, Benjamin D ^a   Wojtkiewkz, Gregory R ^a   Weissleder, Ralph ^a   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPARIN; INDIUM 111;

AIRWAY; ARTICLE; CD8+ T LYMPHOCYTE; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; LYMPHOCYTE MIGRATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 33750820655     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.6991     Document Type: Article

References (41)

1. Gottlieb, A. B., A. D. Luster, D. N. Posnett, and D. M. Carter. 1988. Detection of a γ interferon-induced protein IP-10 in psoriatic plaques. J. Exp. Med. 168: 941-948.
2. Flier, J., D. M. Boorsma, D. P. Bruynzeel, P. J. Van Beek, T. J. Stoof, R. J. Scheper, R. Willemze, and C. P. Tensen. 1999. The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. J. Invest. Dermatol. 113: 574-578.
3. Flier, J., D. M. Boorsma, P. J. van Beek, C. Nieboer, T. J. Stoof, R. Willemze, and C. P. Tensen. 2001. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J. Pathol. 194: 398-405.
4. Mach, F., A. Sauty, A. S. Iarossi, G. K. Sukhova, K. Neote, P. Libby, and A. D. Luster. 1999. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J. Clin. Invest. 104: 1041-1050.
5. Sorensen, T. L., M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V. A. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. M. Strieter, J. L. Frederiksen, and R. M. Ransohoff. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103: 807-815.
6. + T cells are increased in multiple sclerosis and their ligands MIP-1γ and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 96: 6873-6878.
7. Zhao, D. X., Y. Hu, G. G. Miller, A. D. Luster, R. N. Mitchell, and P. Libby. 2002. Differential expression of the IFN-γ-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell α chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J. Immunol. 169: 1556-1560.
8. Melter, M., A. Exeni, M. E. Reinders, J. C. Fang, G. McMahon, P. Ganz, W. W. Hancock, and D. M. Briscoe. 2001. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 104: 2558-2564.
9. Narumi, S., Y. Tominaga, M. Tamara, S. Shimai, H. Okumura, K. Nishioji, Y. Itoh, and T. Okanoue. 1997. Expression of IFN-inducible protein-10 in chronic hepatitis. J. Immunol. 158: 5536-5544.
10. Hancock, W. W., W. Gao, V. Csizmadia, K. L. Faia, N. Shemmeri, and A. D. Luster. 2001. Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 193: 975-980.
11. Heller, E. A., E. Liu, A. M. Tager, Q. Yuan, A. Y. Lin, N. Ahluwalia, K. Jones, S. L. Koehn, V. M. Lok, E. Aikawa, K. J. Moore, A. D. Luster, and R. E. Gerszten. 2006. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 113: 2301-2312.
12. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168: 3195-3204.
13. Christen, U., D. B. McGavern, A. D. Luster, M. G. von Herrath, and M. B. Oldstone. 2003. Among CXCR3 chemokines, IFN-γ-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-ā (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J. Immunol. 171: 6838-6845.
14. Campanella, G. S., E. M. Lee, J. Sun, and A. D. Luster. 2003. CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10). J. Biol. Chem. 278: 17066-17074.
15. Luster, A. D., S. M. Greenberg, and P. Leder. 1995. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182: 219-231.
16. Tanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361: 79-82.
17. Middleton, J., S. Neil, J. Wintle, I. Clark-Lewis, H. Moore, C. Lam, M. Auer, E. Hub, and A. Rot. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91: 385-395.
18. Hoogewerf, A. J., G. S. Kuschert, A. E. Proudfoot, F. Borlat, I. Clark-Lewis, C. A. Power, and T. N. Wells. 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36: 13570-13578.
19. Wang, L., M. Fuster, P. Sriramarao, and J. D. Esko. 2005. Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat. Immunol. 6: 902-910.
20. Wagner, L., O. O. Yang, E. A. Garcia-Zepeda, Y. Ge, S. A. Kalams, B. D. Walker, M. S. Pasternack, and A. D. Luster. 1998. β-Chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391: 908-911.
21. 9-68 binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry 41: 14779-14789.
22. Paavola, C. D., S. Hemmerich, D. Granberger, I. Polsky, A. Bloom, R. Freedman, M. Mulkins, S. Bhakta, D. McCarley, L. Wiesent, et al. 1998. Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J. Biol. Chem. 273: 33157-33165.
23. 13 for receptor binding. Biochemistry 39: 3401-3409.
24. Kim, K. S., K. Rajarathnam, I. Clark-Lewis, and B. D. Sykes. 1996. Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. FEBS Lett. 395: 277-282.
25. Rajarathnam, K., B. D. Sykes, C. M. Kay, B. Dewald, T. Geiser, M. Baggiolini, and I. Clark-Lewis. 1994. Neutrophil activation by monomeric interleukin-8. Science 264: 90-92.
26. Horcher, M., A. Rot, H. Aschauer, and J. Besemer. 1998. IL-8 derivatives with a reduced potential to form homodimers are fully active in vitro and in vivo. Cytokine 10: 1-12.
27. Frevert, C. W., R. B. Goodman, M. G. Kinsella, O. Kajikawa, K. Ballman, I. Clark-Lewis, A. E. Proudfoot, T. N. Wells, and T. R. Martin. 2002. Tissue-specific mechanisms control the retention of IL-8 in lungs and skin. J. Immunol. 168: 3550-3556.
28. Proudfoot, A. E., T. M. Handel, Z. Johnson, E. K. Lau, P. LiWang, I. Clark-Lewis, F. Borlat, T. N. Wells, and M. H. Kosco-Vilbois. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100: 1885-1890.
29. Baltus, T., K. S. Weber, Z. Johnson, A. E. Proudfoot, and C. Weber. 2003. Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood 102: 1985-1988.
30. Colvin, R. A., G. S. Campanella, J. Sun, and A. D. Luster. 2004. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J. Biol. Chem. 279: 30219-30227.
31. Sauty, A., R. A. Colvin, L. Wagner, S. Rochat, F. Spertini, and A. D. Luster. 2001. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). J. Immunol. 167: 7084-7093.
32. Medoff, B. D., E. Seung, J. C. Wain, T. K. Means, G. S. Campanella, S. A. Islam, S. Y. Thomas, L. C. Ginns, N. Grabie, A. H. Lichtman, A. M. Tager, and A. D. Luster. 2005. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J. Exp. Med. 202: 97-110.
33. Grabie, N., M. W. Delfs, J. R. Westlich, V. A. Love, G. Stavrakis, F. Ahmad, C. E. Seidman, J. G. Seidman, and A. H. Lichtman. 2003. IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J. Clin. Invest. 111: 671-680.
34. Booth, V., D. W. Keizer, M. B. Kamphuis, I. Clark-Lewis, and B. D. Sykes. 2002. The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry 41: 10418-10425.
35. Sauty, A., M. Dziejman, R. A. Taha, A. S. Iarossi, K. Neote, E. A. Garcia-Zepeda, Q. Hamid, and A. D. Luster. 1999. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 162: 3549-3558.
36. Johnson, Z., M. H. Kosco-Vilbois, S. Herren, R. Cirillo, V. Muzio, P. Zaratin, M. Carbonatto, M. Mack, A. Smailbegovic, M. Rose, et al. 2004. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 173: 5776-5785.
37. Ali, S., H. Robertson, J. H. Wain, J. D. Isaacs, G. Malik, and J. A. Kirby. 2005. A Non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation. J. Immunol. 175: 1257-1266.
38. Salcedo, R., J. H. Resau, D. Halverson, E. A. Hudson, M. Dambach, D. Powell, K. Wasserman, and J. J. Oppenheim. 2000. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J. 14: 2055-2064.
39. Romagnani, P., F. Annunziato, L. Lasagni, E. Lazzeri, C. Beltrame, M. Francalanci, M. Uguccioni, G. Galli, L. Cosmi, L. Maurenzig, et al. 2001. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107: 53-63.
40. Hastings, R. H., H. G. Folkesson, and M. A. Matthay. 2004. Mechanisms of alveolar protein clearance in the intact lung. Am. J. Physiol. Lung Cell Mol. Physiol. 286: L679-689.
41. Kim, K. J., and A. B. Malik. 2003. Protein transport across the lung epithelial barrier. Am. J. Physiol. Lung Cell Mol. Physiol. 284: L247-L259.